EGFR and lip and oral cavity carcinoma: Interestingly, EGFR and CCND1 oncogenic events are known to act via a common RAS-MAPK Kinase pathway to promote cell cycle and known to act as a driver of oral cancer tumorigenesis [48], [49], [50].